Clinical Trial Update: A Study of GNC-035, a Tetra-specific Antibody, in Participants With Locally Advanced or Metastatic Breast Cancer [Phase 1]

View source ↗

Summary

Phase 1 clinical trial update for GNC-035, a tetra-specific antibody, in breast cancer; the study is currently ACTIVE_NOT_RECRUITING.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• GNC-035

Snippet

Sponsor: Sichuan Baili Pharmaceutical Co., Ltd. | Conditions: Breast Cancer | Phase 1 | Status: ACTIVE_NOT_RECRUITING